Tag: New York Valves 2025
EARLY TAVR: Analysis looks at trial’s outcomes based on guideline recommendations
New analysis of the EARLY TAVR trial, in which investigators examined the prevalence of guideline in...
New York Valves hears 30-day results of low-profile TAVI valve
Thirty-day results of the US early feasibility study assessing the use of the Siegel (Mirus) 8Fr...
Global study shows widening disparity in mitral valve disease outcomes
Degenerative mitral valve disease has doubled in prevalence globally over the last 30 years, and...
One-year results show positive safety and haemodynamic performance for biopolymer surgical mitral valve
Foldax has announced the presentation of one-year results from the India clinical trial of the T...
Improved survival seen following TAVI explant compared to redo procedures
Analysis of real-world US data comparing outcomes after post-transcatheter aortic valve implantation...
